Aaron Fullerton

827 total citations
21 papers, 272 citations indexed

About

Aaron Fullerton is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Aaron Fullerton has authored 21 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Aaron Fullerton's work include Drug-Induced Hepatotoxicity and Protection (8 papers), Immune Cell Function and Interaction (4 papers) and 3D Printing in Biomedical Research (4 papers). Aaron Fullerton is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (8 papers), Immune Cell Function and Interaction (4 papers) and 3D Printing in Biomedical Research (4 papers). Aaron Fullerton collaborates with scholars based in United States, Denmark and United Kingdom. Aaron Fullerton's co-authors include Patricia E. Ganey, Robert A. Roth, Kevin M. Beggs, William R. Proctor, Norman Peterson, Prathap Kumar S. Mahalingaiah, Matteo Piazza, Kazuhisa Miyakawa, Patrick J. Shaw and Michael A. Scott and has published in prestigious journals such as Hepatology, Archives of Biochemistry and Biophysics and Lab on a Chip.

In The Last Decade

Aaron Fullerton

20 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aaron Fullerton United States	11	123	72	57	52	42	21	272
Cerys Lovatt United Kingdom	6	116 0.9×	148 2.1×	51 0.9×	15 0.3×	44 1.0×	6	298
Lu Gan United States	9	87 0.7×	93 1.3×	229 4.0×	64 1.2×	30 0.7×	27	385
Maarten Coonen Netherlands	10	78 0.6×	144 2.0×	43 0.8×	8 0.2×	33 0.8×	15	317
Bernd Diener Germany	7	160 1.3×	84 1.2×	68 1.2×	17 0.3×	187 4.5×	13	394
Erio Barale-Thomas United States	8	37 0.3×	75 1.0×	27 0.5×	59 1.1×	22 0.5×	13	283
Marije Niemeijer Netherlands	10	52 0.4×	168 2.3×	25 0.4×	12 0.2×	31 0.7×	19	340
Nao Yoneda Japan	11	114 0.9×	123 1.7×	62 1.1×	12 0.2×	19 0.5×	29	288
Audrey Baze France	10	109 0.9×	59 0.8×	61 1.1×	8 0.2×	147 3.5×	15	297
Magnus Ölander Sweden	8	25 0.2×	92 1.3×	70 1.2×	15 0.3×	38 0.9×	15	287

Countries citing papers authored by Aaron Fullerton

Since Specialization

Citations

This map shows the geographic impact of Aaron Fullerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Fullerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Fullerton more than expected).

Fields of papers citing papers by Aaron Fullerton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Fullerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Fullerton. The network helps show where Aaron Fullerton may publish in the future.

Co-authorship network of co-authors of Aaron Fullerton

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Fullerton. A scholar is included among the top collaborators of Aaron Fullerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Fullerton. Aaron Fullerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brusilovsky, Michael, Elizabeth Buck, W. Clark Bacon, et al.. (2025). Autologous Organoid‐T Cell Co‐Culture Platform for Modeling of Immune‐Mediated Drug‐Induced Liver Injury. Advanced Science. 12(43). e08584–e08584.

Rouquié, David, Andreas Bender, Jaime H. Cheah, et al.. (2025). The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment. Toxicological Sciences. 208(2). 225–232. 1 indexed citations

Klein, Jessica A., et al.. (2025). The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity. Frontiers in Cell and Developmental Biology. 13. 1508820–1508820. 2 indexed citations

Kang, Michael S., Eugene C. Chen, Julia Y. Co, et al.. (2024). Complex in vitro models positioned for impact to drug testing in pharma: a review. Biofabrication. 16(4). 42006–42006. 7 indexed citations

Fullerton, Aaron, Jochen Brumm, Tomomi Kiyota, et al.. (2020). In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk. Archives of Toxicology. 94(9). 3185–3200. 6 indexed citations

Wilson, Jennifer L., et al.. (2020). An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias. PLoS Computational Biology. 16(7). e1007620–e1007620. 4 indexed citations

Peterson, Norman, Prathap Kumar S. Mahalingaiah, Aaron Fullerton, & Matteo Piazza. (2020). Application of microphysiological systems in biopharmaceutical research and development. Lab on a Chip. 20(4). 697–708. 24 indexed citations

Stevens, Brett M., Amanda Winters, Jonathan A. Gutman, et al.. (2019). Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis. Leukemia Research. 81. 43–49. 4 indexed citations

Kümler, Iben, Rikke Løvendahl Eefsen, Peter G. Sørensen, et al.. (2019). An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine. Cancer Chemotherapy and Pharmacology. 84(2). 441–446. 5 indexed citations

10.

Kümler, Iben, Peter G. Sørensen, Jesper Andreas Palshof, et al.. (2018). Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics. Cancer Chemotherapy and Pharmacology. 83(1). 169–178. 11 indexed citations

11.

Kozlowski, Cleopatra, et al.. (2018). Proof of Concept for an Automated Image Analysis Method to Quantify Rat Bone Marrow Hematopoietic Lineages on H&E Sections. Toxicologic Pathology. 46(3). 336–347. 8 indexed citations

12.

Beggs, Kevin M., Ashley R. Maiuri, Aaron Fullerton, et al.. (2015). Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related. Toxicology. 331. 35–46. 18 indexed citations

13.

Dambach, Donna M., Dinah Misner, Mathew Brock, et al.. (2015). Safety Lead Optimization and Candidate Identification: Integrating New Technologies into Decision-Making. Chemical Research in Toxicology. 29(4). 452–472. 21 indexed citations

14.

Proctor, William R., Mala Chakraborty, Aaron Fullerton, et al.. (2014). Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology. 60(5). 1741–1752. 14 indexed citations

15.

Beggs, Kevin M., Aaron Fullerton, Kazuhisa Miyakawa, Patricia E. Ganey, & Robert A. Roth. (2013). Molecular Mechanisms of Hepatocellular Apoptosis Induced by Trovafloxacin-Tumor Necrosis Factor-alpha Interaction. Toxicological Sciences. 137(1). 91–101. 28 indexed citations

16.

Fullerton, Aaron, Robert A. Roth, & Patricia E. Ganey. (2013). Pretreatment With TCDD Exacerbates Liver Injury From Concanavalin A: Critical Role for NK Cells. Toxicological Sciences. 136(1). 72–85. 13 indexed citations

17.

Fullerton, Aaron, Robert A. Roth, & Patricia E. Ganey. (2012). 2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury. Toxicology and Applied Pharmacology. 266(2). 317–327. 12 indexed citations

18.

Fullerton, Aaron, et al.. (2011). Natural Killer Cells Mediate Severe Liver Injury in a Murine Model of Halothane Hepatitis. Toxicological Sciences. 120(2). 507–518. 27 indexed citations

19.

Shaw, Patrick J., Aaron Fullerton, Michael A. Scott, Patricia E. Ganey, & Robert A. Roth. (2009). The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability. Toxicology and Applied Pharmacology. 236(3). 293–300. 21 indexed citations

20.

Huynh, Tien, et al.. (2006). Reversible covalent inhibition of a phenol sulfotransferase by coenzyme A. Archives of Biochemistry and Biophysics. 457(2). 197–204. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact